136 related articles for article (PubMed ID: 14981923)
1. Cytotoxic activity of tropolones against human oral tumor cell lines.
Wakabayashi H; Yokoyama K; Hashiba K; Hashimoto K; Kikuchi H; Nishikawa H; Kurihara T; Satoh K; Shioda S; Muto S; Terakubo S; Nakashima H; Motohashi N; Sakagami H
Anticancer Res; 2003; 23(6C):4757-63. PubMed ID: 14981923
[TBL] [Abstract][Full Text] [Related]
2. Cytotoxic activity of azulenes against human oral tumor cell lines.
Wakabayashi H; Hashiba K; Yokoyama K; Hashimoto K; Kikuchi H; Nishikawa H; Kurihara T; Satoh K; Shioda S; Saito S; Kusano S; Nakashima H; Motohashi N; Sakagami H
Anticancer Res; 2003; 23(6C):4747-55. PubMed ID: 14981922
[TBL] [Abstract][Full Text] [Related]
3. Tumor-specific cytotoxicity and type of cell death induced by benzo[b]cyclohept[e][1,4]oxazine and 2-aminotropone derivatives.
Narita T; Suga A; Kobayashi M; Hashimoto K; Sakagami H; Motohashi N; Kurihara T; Wakabayashi H
Anticancer Res; 2009 Apr; 29(4):1123-30. PubMed ID: 19414354
[TBL] [Abstract][Full Text] [Related]
4. Tumor-specificity and type of cell death induced by trihaloacetylazulenes in human tumor cell lines.
Sekine T; Takahashi J; Nishishiro M; Arai A; Wakabayashi H; Kurihara T; Kobayashi M; Hashimoto K; Kikuchi H; Katayama T; Kanda Y; Kunii S; Motohashi N; Sakagami H
Anticancer Res; 2007; 27(1A):133-43. PubMed ID: 17352225
[TBL] [Abstract][Full Text] [Related]
5. Cytotoxic activity of vitamins K1, K2 and K3 against human oral tumor cell lines.
Okayasu H; Ishihara M; Satoh K; Sakagami H
Anticancer Res; 2001; 21(4A):2387-92. PubMed ID: 11724297
[TBL] [Abstract][Full Text] [Related]
6. Cytotoxic activity of azulenequinones against human oral tumor cell lines.
Wakabayashi H; Nishishiro M; Arikawa S; Hashimoto K; Kikuchi H; Nishikawa H; Kurihara T; Terakubo S; Shoji Y; Nakashima H; Motohashi N; Sakagami H
Anticancer Res; 2005; 25(1A):305-12. PubMed ID: 15816552
[TBL] [Abstract][Full Text] [Related]
7. Tumor-specificity and type of cell death induced by vitamin K2 derivatives and prenylalcohols.
Sakagami H; Hashimoto K; Suzuki F; Ishihara M; Kikuchi H; Katayama T; Satoh K
Anticancer Res; 2008; 28(1A):151-8. PubMed ID: 18383839
[TBL] [Abstract][Full Text] [Related]
8. Cytotoxic activity of styrylchromones against human tumor cell lines.
Momoi K; Sugita Y; Ishihara M; Satoh K; Kikuchi H; Hashimoto K; Yokoe I; Nishikawa H; Fujisawa S; Sakagami H
In Vivo; 2005; 19(1):157-63. PubMed ID: 15796168
[TBL] [Abstract][Full Text] [Related]
9. Apoptosis-inducing activity of trihaloacetylazulenes against human oral tumor cell lines.
Akatsu Y; Ohshima N; Yamagishi Y; Nishishiro M; Wakabayashi H; Kurihara T; Kikuchi H; Katayama T; Motohashi N; Shoji Y; Nakashima H; Sakagami H
Anticancer Res; 2006; 26(3A):1917-23. PubMed ID: 16827125
[TBL] [Abstract][Full Text] [Related]
10. Induction of tumor-specific cytotoxicity and apoptosis by doxorubicin.
Suzuki F; Hashimoto K; Kikuchi H; Nishikawa H; Matsumoto H; Shimada J; Kawase M; Sunaga K; Tsuda T; Satoh K; Sakagami H
Anticancer Res; 2005; 25(2A):887-93. PubMed ID: 15868924
[TBL] [Abstract][Full Text] [Related]
11. Induction of apoptosis by morphine in human tumor cell lines in vitro.
Hatsukari I; Hitosugi N; Ohno R; Hashimoto K; Nakamura S; Satoh K; Nagasaka H; Matsumoto I; Sakagami H
Anticancer Res; 2007; 27(2):857-64. PubMed ID: 17465212
[TBL] [Abstract][Full Text] [Related]
12. Re-evaluation of tumor-specific cytotoxicity of mitomycin C, bleomycin and peplomycin.
Sasaki M; Okamura M; Ideo A; Shimada J; Suzuki F; Ishihara M; Kikuchi H; Kanda Y; Kunii S; Sakagami H
Anticancer Res; 2006; 26(5A):3373-80. PubMed ID: 17094455
[TBL] [Abstract][Full Text] [Related]
13. Tumor-specific cytotoxicity and type of cell death induced by naphtho[2,3-b]furan-4,9-diones and related compounds in human tumor cell lines: relationship to electronic structure.
Takano A; Hashimoto K; Ogawa M; Koyanagi J; Kurihara T; Wakabayashi H; Kikuchi H; Nakamura Y; Motohashi N; Sakagami H; Yamamoto K; Tanaka A
Anticancer Res; 2009 Jan; 29(1):455-64. PubMed ID: 19331186
[TBL] [Abstract][Full Text] [Related]
14. Induction of non-apoptotic cell death by morphinone in human promyelocytic leukemia HL-60 cells.
Takeuchi R; Hoshijima H; Nagasaka H; Chowdhury SA; Kikuchi H; Kanda Y; Kunii S; Kawase M; Sakagami H
Anticancer Res; 2006; 26(5A):3343-8. PubMed ID: 17094451
[TBL] [Abstract][Full Text] [Related]
15. Cytotoxic activity of polyprenylalcohols and vitamin K2 derivatives.
Ishihara M; Takayama F; Toguchi M; Nakano K; Yasumoto E; Nakayachi T; Satoh K; Sakagami H
Anticancer Res; 2000; 20(6B):4307-13. PubMed ID: 11205263
[TBL] [Abstract][Full Text] [Related]
16. Tumor-specific cytotoxicity and type of cell death induced by benzocycloheptoxazines in human tumor cell lines.
Murayama H; Miyahara K; Wakabayashi H; Kurihara T; Hashimoto K; Amano O; Kikuchi H; Nakamura Y; Kanda Y; Kunii S; Motohashi N; Sakagami H
Anticancer Res; 2008; 28(2A):1069-78. PubMed ID: 18507056
[TBL] [Abstract][Full Text] [Related]
17. Cytotoxic activity of saponins from Camassia leichtlinii against human oral tumor cell lines.
Furuya S; Takayama F; Mimaki Y; Sashida Y; Satoh K; Sakagami H
Anticancer Res; 2001; 21(2A):959-64. PubMed ID: 11396188
[TBL] [Abstract][Full Text] [Related]
18. Effects of anticancer drugs, metals and antioxidants on cytotoxic activity of benzothiepins/benzoxepins.
Terasawa K; Hosoya H; Sugita Y; Yokoe I; Sakagami H
Anticancer Res; 2000; 20(5A):2951-4. PubMed ID: 11062706
[TBL] [Abstract][Full Text] [Related]
19. Cytotoxicity and radical modulating activity of Moxa smoke.
Sakagami H; Matsumoto H; Satoh K; Shioda S; Ali CS; Hashimoto K; Kikuchi H; Nishikawa H; Terakubo S; Shoji Y; Nakashima H; Shimada J
In Vivo; 2005; 19(2):391-7. PubMed ID: 15796203
[TBL] [Abstract][Full Text] [Related]
20. Tumor-specific cytotoxicity of 3,5-dibenzoyl-1,4-dihydropyridines.
Morshed SR; Hashimoto K; Murotani Y; Kawase M; Shah A; Satoh K; Kikuchi H; Nishikawa H; Maki J; Sakagami H
Anticancer Res; 2005; 25(3B):2033-8. PubMed ID: 16158941
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]